You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 1 | BMC Infectious Diseases

Figure 1

From: Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm

Figure 1

Estimated association between initial ProADM values and the risk of adverse events (A) and death (B). Estimated association between initial ProADM values and the risk of adverse events (upper black line) and death (lower blue line). Estimates are based on generalized additive models and shaded gray regions correspond to (point-wise) 95% confidence intervals. The rugs at the bottom of the plots display the distribution of the biomarker. Solid lines (and confidence intervals) based on imputed data, dashed lines based on complete-case analysis.

Back to article page